Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial
Hurwitz BE, Klaus JR, Llabre MM, Gonzalez A, Lawrence PJ, Maher KJ
Published in Archives of Internal Medicine
Methodology
Double-blind placebo-controlled trial of 200 microg/day high-selenium yeast for 9 months in HIV-1 infected adults
Key Findings
Increases in serum selenium were associated with suppression of HIV-1 viral load and a corresponding rise in CD4 count.
Conclusions
Selenium supplementation that raises serum selenium suppresses HIV-1 viral burden.
Limitations
Effect confined to selenium responders; single-centre; modest sample.
Supplements Studied
Selenium supplementation suppressed HIV-1 viral load and raised CD4 count.
Outcomes Measured
Increases in serum selenium were associated with suppression of HIV-1 viral load and a corresponding rise in CD4 count.
Study Details
Access Study
Disclosures
Funding
NIH / NIMH
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.